Stereotactic Body Radiation Therapy: Quality of Life vs. Possible Risks

The evolution of prostate cancer (PCa) treatment often seems like a moving target. Suddenly there’s a revolutionary new treatment, or an exciting development in an existing one. Patients benefit from technological advances, gains in experience, and improved scientific knowledge—but even the most promising must survive the test of time, since unintended consequences can show up keep reading

A PROMIS is a Promise for Multiparametric MRI

Prostate MRI - Sperling Prostate Center
In the world of prostate cancer (PCa) diagnosis, the year 2017 began with the January 19 online publication of another brilliant study out of the University College London and other British centers of clinical research.[i] The study, called PROMIS, was a comparison between multiparametric MRI (mpMRI) vs. TRUS biopsy in terms of diagnostic accuracy. Actually, keep reading
This site uses cookies to analyze traffic and user behavior, protect your privacy, and provide you with the best user experience. Learn more.
close-image